Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

¥6.40As of Sun 8 Nov 2026, 12:00 UTC
SSE:600613Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (7.22%)
Div yield 1.09%
ROE 0.65%
Drug Manufacturers (General)
Beta (5Y) 0.74
PE TTM 381.2
TSR TTM 0.35%
Mkt cap ¥3.219B
ROIC 1.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.74
20.98%
(43.68%)
Hold 12|0|8|7|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.12
0.13
0.13
23.73%
17.53%
16.50%
18.36%
Revenue¥M
298.4
289.8
298.6
290.1
15.12%
13.08%
10.33%
1.20%
Peers (US$482.5M)
Cap (US$)
PE
619.8M
46.76x
427.7M
19.58x
498.1M
39.99x
Capital
TTM
5Y
10Y
Leveragex
0.653
0.175
0.144
EBIT/Intx
0.887
0.508
0.468
Own earn%
(34.46)
20.11
11.95
Sh yield%
50.05
51.26
48.16
Owners
Insiders/Inst%
11.32
72.25
Short interest%
3.63
SBC / revenue%
1.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
27–32
$1 testx
—
Incr. ROIC%
62